HaploKun Whole Exome Sequencing for Solid Tumors (Clinical)

High-throughput DNA sequencing service for clinical sample analysis and genomic profiling. This service enables identification of disease-associated genetic variants for precision medicine applications.

Genomic sequencing panel for cancer-related mutation and biomarker detection. Supports precision oncology treatment planning and selection.

Whole-exome sequencing-based genetic detection solution for comprehensive genomic analysis and disease risk assessment. Identifies pathogenic variants across the entire protein-coding genome to support clinical diagnosis, carrier screening, and personalized treatment planning.

Comprehensive genomic sequencing platform for cancer diagnosis and characterization. Utilizes next-generation sequencing technology to identify genetic mutations and alterations in tumor samples. Supports treatment selection and clinical decision-making for oncology patients.

Comprehensive genomic diagnostic platform providing precision analysis for disease detection and personalized treatment planning. Integrates molecular-based technologies with clinical interpretation for accurate patient stratification.

A clinically validated in vitro diagnostic NGS panel for tumor analysis and monitoring. Enables detection of low-frequency variants for precise patient monitoring and informed treatment decisions. Designed for confident calling of genomic alterations in oncology clinical practice.

Comprehensive gene sequencing preparation kit targeting exon regions for clinical genomic analysis. Designed for targeted genetic profiling and diagnostic applications.

In vitro diagnostic devices for oncology applications focusing on genetic mutation detection and biomarker analysis. Supports clinical decision-making through comprehensive molecular profiling.

Advanced genetic analysis services including NGS (Next Generation Sequencing), clinical exome sequencing, and molecular karyotyping. IntroLab specializes in genetic diagnostics with expert interpretation by medical geneticists.

Genetic testing for cancer predisposition and somatic cancer variants to identify individuals at risk or with diagnosed malignancies. Includes comprehensive sequencing with clinical validation and genetic counselling.

Comprehensive multigene panel for hereditary disease identification and cancer risk assessment. Provides clinical-grade analysis with detailed genomic reporting.

EasyPGX® is a dry qPCR-based diagnostic test for pharmacogenetic and tumor profiling in oncology. It enables rapid molecular analysis of patient genetic variants to guide precision treatment selection and reduce turnaround time for clinical decision-making.